Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT05624996 2026-01-14

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Phase 3 Recruiting

474 enrolled

Thoracic

Lung Neoplasms

NCT06378866 2025-12-26

DIVINE

Phase 2 Recruiting

532 enrolled

Genitourinary

Prostatic Neoplasms

NCT06499870 2025-10-21

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

Phase 2 Recruiting

50 enrolled

Genitourinary

Prostate Adenocarcinoma

NCT06549478 2025-09-17

Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases

Phase 1 Recruiting

24 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06546267 2025-06-11

PROST-ART

Recruiting

2,500 enrolled

Genitourinary

Lymphatic Metastasis, Prostatic Neoplasms

NCT06306170 2025-04-22

GYN-ART

Recruiting

1,000 enrolled

Radiation Injuries, Disease Progression

NCT06216171 2024-09-27

ProHEART

Phase NA Recruiting

30 enrolled

Head & Neck

Head and Neck Neoplasms

NCT05328505 2024-09-26

MIDAS-Prostate

Phase NA Recruiting

80 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms, Recurrence

Clinical Trials

RTL-DART

METRO

Prostate Adaptive Radiation Therapy

Pelvis ART

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

DIVINE

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases

PROST-ART

GYN-ART

ProHEART

MIDAS-Prostate